Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Randomized Clinical Trial of Arginine Hydrochloride Administration to Reduce Duration of Diabetic Ketoacidosis in Patients With Type 2 Diabetes

NCT07167693 is registered in ClinicalTrials.gov with David K Carroll as lead sponsor.

NCT NCT07167693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07167693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Randomized Clinical Trial of Arginine Hydrochloride Administration to Reduce Duration of Diabetic Ketoacidosis in Patients With Type 2 Diabetes
Lead sponsor
David K Carroll
Phase
Phase 1/2
Overall status
Recruiting
Start date
December 19, 2025
Completion date
December 31, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes (dm), diabetic ketoacidosis, hyperglycaemia (diabetic), ketosis prone diabetes